Lumos Diagnostics Holdings Limited (LDXHF)
OTCMKTS · Delayed Price · Currency is USD
0.0858
+0.0358 (71.60%)
Jul 31, 2025, 2:09 PM EDT
LDXHF Revenue
Lumos Diagnostics Holdings had revenue of $6.31M in the half year ending December 31, 2024, with 23.96% growth. This brings the company's revenue in the last twelve months to $14.67M, up 78.61% year-over-year. In the fiscal year ending June 30, 2024, Lumos Diagnostics Holdings had annual revenue of $11.13M with 5.66% growth.
Revenue (ttm)
14.67M
Revenue Growth
+78.61%
P/S Ratio
2.67
Revenue / Employee
n/a
Employees
n/a
Market Cap
39.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 11.13M | 596.00K | 5.66% |
| Jun 30, 2023 | 10.54M | -1.10M | -9.42% |
| Jun 30, 2022 | 11.63M | -7.22M | -38.32% |
| Jun 30, 2021 | 18.85M | 13.06M | 225.25% |
| Jun 30, 2020 | 5.80M | 1.32M | 29.54% |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
Lumos Diagnostics Holdings News
- 6 months ago - LH slashes new projects as economy slows - Bangkok Post
- 7 months ago - LH seen taking more cautious approach - Bangkok Post
- 7 months ago - Land & Houses seen taking more cautious approach - Bangkok Post